Mirae Asset Global Investments’s Keros Therapeutics KROS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.9K | Buy |
1,569
+209
| +15% | +$2.79K | ﹤0.01% | 1395 |
|
2025
Q1 | $14.7K | Buy |
1,360
+10
| +0.7% | +$108 | ﹤0.01% | 1423 |
|
2024
Q4 | $22.2K | Sell |
1,350
-7
| -0.5% | -$115 | ﹤0.01% | 1407 |
|
2024
Q3 | $76.6K | Buy |
1,357
+280
| +26% | +$15.8K | ﹤0.01% | 1230 |
|
2024
Q2 | $48.5K | Sell |
1,077
-12,072
| -92% | -$544K | ﹤0.01% | 1256 |
|
2024
Q1 | $662K | Buy |
13,149
+251
| +2% | +$12.6K | ﹤0.01% | 1766 |
|
2023
Q4 | $513K | Buy |
12,898
+404
| +3% | +$16.1K | ﹤0.01% | 1956 |
|
2023
Q3 | $398K | Buy |
12,494
+950
| +8% | +$30.3K | ﹤0.01% | 1997 |
|
2023
Q2 | $463K | Buy |
11,544
+5
| +0% | +$201 | ﹤0.01% | 1981 |
|
2023
Q1 | $493K | Buy |
+11,539
| New | +$493K | ﹤0.01% | 1931 |
|